Newpace Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Newpace General Information

Description

Manufacturer of an implantable defibrillator system designed to measure heart performance. The company's system uses implantable subcutaneous string defibrillators with monitoring capabilities that require one hour of wireless recharge in a year, enabling users to have a device in the event of sudden cardiac arrest.

Contact Information

Website
www.newpacemedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Granit 13, North Industrial Park
  • POB 3112
  • Caesarea 3088900
  • Israel
+972
Primary Industry
Monitoring Equipment
Vertical(s)
Manufacturing, Digital Health, Mobile
Corporate Office
  • Granit 13, North Industrial Park
  • POB 3112
  • Caesarea 3088900
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newpace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Generating Revenue
3. Grant 31-Mar-2021 Completed Generating Revenue
2. Grant 16-Oct-2017 $59.1K $2M Completed Generating Revenue
1. Early Stage VC 01-Aug-2015 $2M $2M Completed Generating Revenue
To view Newpace’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Newpace Patents

  • 65

    Total Documents Applications and Grants

  • Total Patents Families

  • 50

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Newpace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250099747-A1 Flexible and stretchable wearable defibrillator patch Pending 03-Apr-2022
US-20230080043-A1 Automated cardiac defibrillator pacer with integrated cardiac assist device Inactive 20-Jan-2020
US-20220355122-A1 Automated wearable belt cardiac defibrillator Pending 27-Aug-2019
EP-4021566-A2 Automated wearable belt cardiac defibrillator Active 27-Aug-2019
CA-3145977-A1 Automated wearable belt cardiac defibrillator Pending 27-Aug-2019 A61N1/3904
To view Newpace’s complete patent history, request access »

Newpace Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newpace Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon Europe Other
Horizon 2020 Government
BioStar Capital Venture Capital Minority
Haisco Pharmaceutical Group Company Corporation Minority
BioTelemetry Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Newpace FAQs

  • When was Newpace founded?

    Newpace was founded in 2012.

  • Where is Newpace headquartered?

    Newpace is headquartered in Caesarea, Israel.

  • What is the size of Newpace?

    Newpace has 10 total employees.

  • What industry is Newpace in?

    Newpace’s primary industry is Monitoring Equipment.

  • Is Newpace a private or public company?

    Newpace is a Private company.

  • What is Newpace’s current revenue?

    The current revenue for Newpace is .

  • How much funding has Newpace raised over time?

    Newpace has raised $2M.

  • Who are Newpace’s investors?

    Horizon Europe, Horizon 2020, BioStar Capital, Haisco Pharmaceutical Group Company, and BioTelemetry are 5 of 6 investors who have invested in Newpace.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »